Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

(247,360,000) (230,836,000) ------------ ------------ Total stockholders' equity 901,000 15,595,000 ------- ---------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $23,127,000 $23,057,000 =========== ===========



                                         2009           2008           2007
                                         ----           ----           ----

    Contract manufacturing revenue   $12,963,000     $5,897,000     $3,492,000
    Government contract revenue        5,013,000              -              -
    License revenue                      175,000        196,000        216,000
                                         -------        -------        -------

      Total revenues                  18,151,000      6,093,000      3,708,000

    Cost of contract manufacturing     9,064,000      4,804,000      3,296,000
    Research and development          18,424,000     18,279,000     15,876,000
    Selling, general and
     administrative                    6,979,000      7,150,000      6,446,000
                                       ---------      ---------      ---------

      Total costs and expenses        34,467,000     30,233,000     25,618,000
                                      ----------     ----------     ----------

    LOSS FROM OPERATIONS             (16,316,000)   (24,140,000)  (21,910,000)

    Interest and other income            200,000        989,000      1,160,000
    Interest and other expense          (408,000)       (25,000) 
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
(Date:11/28/2014)... 2014 Dr. Paul Vitenas, one of the ... & Glow Holiday Event for those in the area that would ... practice. Glitter & Glow will take place on December 11, 2014, ... in the heart of Houston at 4208 Richmond Ave. , ... that you will come and celebrate the season with us on ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Secura ... the few insurance marketing organizations in the country ... and asset protection marketplace. Secura Consultants is proud ... with Principal Financial Group, a leading global financial ... ownership interests. With the ownership interest comes the ...
(Date:11/28/2014)... 2014 (HealthDay News) -- Celebration can quickly turn ... Thanksgiving Day, experts say. Over the last decade, ... occurred while people were using turkey fryers, according to ... actually cared for a patient who tried to deep ... done in any circumstances," Dr. Arthur Sanford, a burn ...
(Date:11/28/2014)... Kramer HealthDay Reporter , THURSDAY, ... the kitchen, through cooking classes or at home, may make ... recent review. Cooking programs and classes for children seem ... the new research. And, although the review didn,t look at ... programs might help children develop long-lasting healthy habits. ...
(Date:11/28/2014)... November 28, 2014 PreDiabetes ... and treatment, helped employees learn their risk for ... blood screening at a local school in partnership ... Work initiative. , As the Presenting Sponsor ... , PreDiabetes Centers is co-hosting diabetes-prevention presentations at ...
Breaking Medicine News(10 mins):Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Want Kids to Eat Better? Get Them Cooking 2Health News:Want Kids to Eat Better? Get Them Cooking 3Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... Study finds mortality and survival rates equal for both ... Minimally-invasive laparoscopic surgery and open surgery for colon cancer ... from 12 international studies involving over 3,300 patients. ... afraid that laparoscopy might impair survival in colorectal cancer ...
... not establish safe-limit price as guide for avoiding exposure ... you bought from a hip young street artist may be ... skin. , A new report finds that many pairs of ... stores and artists contain nickel, which can cause dermatitis on ...
... Bed & Back; Merger Sets Up Healthy ... Owned Back Retail Chain, LORTON, Va., May 16 ... home and workplace back wellness created an,ergonomic revolution, has ... Back. Healthy Back,s 18 stores and ecommerce division,claimed 2007 ...
... readings, study says , , FRIDAY, May 16 (HealthDay News) -- ... hormone secreted by the parathyroid glands may increase the risk ... , The Dutch study, published in the May issue ... by researchers that vitamin D, depression and other psychiatric illnesses ...
... Month-long Campaign to Emphasize the Importance of Oral ... National dental insurer United,Concordia Dental is celebrating ... and the British Dental Health Foundation to,promote the ... May 18,this year,s event is launching in the ...
... clinical trial has found that the experimental targeted therapy ... metastatic kidney cancer whose disease had worsened on other ... MD, an attending physician at Memorial Sloan-Kettering Cancer Center ... at the annual meeting of the American Society for ...
Cached Medicine News:Health News:Outcomes Similar for Laparoscopic, Open Colon Cancer Surgeries 2Health News:Cheaper Earrings More Likely to Contain Nickel 2Health News:Cheaper Earrings More Likely to Contain Nickel 3Health News:The Back Wars Come to a Close 2Health News:Low Vitamin D Tied to Depression in Older Adults 2Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Drug fends off kidney cancer progression 2
(Date:11/27/2014)... Nov. 27, 2014 - New ... Research - JIN Co., Ltd. will launch JINS ... price of 500,000 yen or $5,000 (without tax /including two ... "ACADEMIC PACK" is a dedicated solution of "JINS MEME" to ... analyze deep data* generated by electrooculography and six-axis sensors without ...
(Date:11/26/2014)... 26, 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today ... raise approximately $3.3 million at a price of $0.30 ... healthcare focused investor. Each unit consists of one common ... purchase warrant. Each whole warrant entitles the holder to ... for a period of five years from closing.  ...
(Date:11/26/2014)... Nov. 26, 2014  Genomic Health, Inc. (Nasdaq: ... Chairman, Chief Executive Officer and President, will participate in ... at The New York Palace Hotel in ... 11:30 am Eastern Time (ET). To access ... call, go to the  Investor Relations  section of the ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3
... a leading developer of innovative catheters and stents for ... closing of a $17M Round D financing.  The financing ... based EDB Investments (,EDBI,) with strong support from current ... are delighted to have Bio*One join our group of ...
... Arable Corporation ( ) has announced the launch ... the clinical trial industry.  Whereas traditional CTMS systems have ... CTMS and EDC capabilities without the traditionally high start-up ... or CROs to manage the planning and implementation of ...
Cached Medicine Technology:TriReme Medical Announces $17 Million Series D Financing 2Arable Corporation Announces New Technology for Clinical Trial Industry 2
This table has adjustable height, an integral leg, and blade post. Includes a standard 2" (5 cm) pad....
... is designed for use without ... allowing for full C-Arm access. ... stored onboard when more stability ... quickly slide into standard sockets ...
... The onboard rail clamps ... O.R. tables and stretchers. ... any need for lifting. ... a stable surface combined ...
... The powered torso and ... Orthopedic Trauma Table simultaneously lift ... independent lift mechanism raises and ... for precise positioning. A wide ...
Medicine Products: